Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric oxide nasal spray plus hypromellose in mild COVID-19
TCTR20220510010Phase 3Recruiting
- Sponsor
- Fresh Body
- Start
- Apr 2022
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nitric oxide in coronavirus disease 2019 (COVID-19), sponsored by Fresh Body. Started Apr 2022; status: recruiting.
02
Drugs
nitric oxide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20220510010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220510010.